| Heidi Smith, ARNP | |
|
1000 4th St Sw, Mason City, IA 50401-2800 | |
| (641) 428-6300 | |
| (641) 428-6374 |
| Full Name | Heidi Smith |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 1000 4th St Sw, Mason City, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588289672 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SA2200X | Clinical Nurse Specialist - Adult Health | H158948 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercyone North Iowa Medical Center | Mason city, IA | Hospital |
| Franklin General Hospital | Hampton, IA | Hospital |
| Hancock County Health System | Britt, IA | Hospital |
| Kossuth Regional Health Center | Algona, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Iowa Mercy Clinics | 7810809076 | 242 |
News Archive
Response Genetics Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, and Genetic Technologies Ltd. (ASX: GTG; NASDAQ: GENE), the leading private genetic testing laboratory in Australia, today announced an exclusive distribution and services agreement.
Ligand Pharmaceuticals Incorporated today announced that GlaxoSmithKline was granted marketing authorization from the European Commission for Revolade® (eltrombopag) for the oral treatment of thrombocytopenia (reduced platelet count) in adults with the blood disorder chronic immune (idiopathic) thrombocytopenic purpura (ITP).
TomTec Imaging Systems announces the FDA 510(k) clearance for its new 2D Cardiac Performance Analysis MR software solution.
Rockefeller Group Technology Solutions, Inc., a division of Rockefeller Group International, Inc., today announced the launch of a multi-vendor Healthcare Mobile Technology Roadshow throughout the tri-state region.
Discovered back in the 1600s quinine was the first effective treatment in the fight against malaria - and it continues to be a commonly used treatment against this devastating disease. But the drug is associated with a long list of side effects which can range from sickness and headaches to blindness, deafness and in rare cases death - and until now no one knew why.
› Verified 8 days ago
| Entity Name | North Iowa Mercy Clinics |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780278242 PECOS PAC ID: 7810809076 Enrollment ID: O20031105000273 |
News Archive
Response Genetics Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, and Genetic Technologies Ltd. (ASX: GTG; NASDAQ: GENE), the leading private genetic testing laboratory in Australia, today announced an exclusive distribution and services agreement.
Ligand Pharmaceuticals Incorporated today announced that GlaxoSmithKline was granted marketing authorization from the European Commission for Revolade® (eltrombopag) for the oral treatment of thrombocytopenia (reduced platelet count) in adults with the blood disorder chronic immune (idiopathic) thrombocytopenic purpura (ITP).
TomTec Imaging Systems announces the FDA 510(k) clearance for its new 2D Cardiac Performance Analysis MR software solution.
Rockefeller Group Technology Solutions, Inc., a division of Rockefeller Group International, Inc., today announced the launch of a multi-vendor Healthcare Mobile Technology Roadshow throughout the tri-state region.
Discovered back in the 1600s quinine was the first effective treatment in the fight against malaria - and it continues to be a commonly used treatment against this devastating disease. But the drug is associated with a long list of side effects which can range from sickness and headaches to blindness, deafness and in rare cases death - and until now no one knew why.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Heidi Smith, ARNP 1000 4th St Sw, Mason City, IA 50401-2800 Ph: (641) 428-6300 | Heidi Smith, ARNP 1000 4th St Sw, Mason City, IA 50401-2800 Ph: (641) 428-6300 |
News Archive
Response Genetics Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, and Genetic Technologies Ltd. (ASX: GTG; NASDAQ: GENE), the leading private genetic testing laboratory in Australia, today announced an exclusive distribution and services agreement.
Ligand Pharmaceuticals Incorporated today announced that GlaxoSmithKline was granted marketing authorization from the European Commission for Revolade® (eltrombopag) for the oral treatment of thrombocytopenia (reduced platelet count) in adults with the blood disorder chronic immune (idiopathic) thrombocytopenic purpura (ITP).
TomTec Imaging Systems announces the FDA 510(k) clearance for its new 2D Cardiac Performance Analysis MR software solution.
Rockefeller Group Technology Solutions, Inc., a division of Rockefeller Group International, Inc., today announced the launch of a multi-vendor Healthcare Mobile Technology Roadshow throughout the tri-state region.
Discovered back in the 1600s quinine was the first effective treatment in the fight against malaria - and it continues to be a commonly used treatment against this devastating disease. But the drug is associated with a long list of side effects which can range from sickness and headaches to blindness, deafness and in rare cases death - and until now no one knew why.
› Verified 8 days ago
Mrs. Amy Marie Joslin, DNP, ARNP, AGCNS-BC Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 250 S Crescent Dr, Mason City, IA 50401 Phone: 641-494-5300 | |
Ms. Jennifer Castle, ARNP Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 1000 4th St Sw, Mason City, IA 50401 Phone: 641-428-6300 Fax: 641-428-6347 |